Study record

Downregulation of circulating MOTS-c levels in patients with coronary endothelial dysfunction

Qin Q, Delrio S, Wan J et al. · Int J Cardiol · 2018

Human obs.SeveralEvidence tier BAlso: Tissue / sample study (ex vivo)

What this study reported

Found lower plasma MOTS-c in patients with coronary endothelial dysfunction than in those with normal endothelial function, and plasma MOTS-c correlated positively with microvascular and epicardial endothelial function. In aortic rings from rats and renal artery stenosis mice, MOTS-c pretreatment had no direct vasoactive effect but was associated with improved responsiveness to acetylcholine.

Limitations

Small cross-sectional sample from a single clinical setting, so direction of association cannot be established; ex-vivo exposure used a single pretreatment condition.

Study record

Annotated fields for this study
Study modelHuman observational
Substance studiedSeveralMore than one of these is central to the paper (common for reviews).
Specieshuman, rat, mouse
System studiedPatients undergoing coronary angiography and endothelial function testing; aortic rings from rats and renal artery stenosis mice
Populationpatients with recurrent angina and no structural coronary lesions, with or without coronary endothelial dysfunction
DesignCross-sectional case comparison with ex-vivo vascular reactivity experiments
Sample size as reported40 patients (20 with endothelial dysfunction, 20 with normal endothelial function)
Control grouppatients with normal coronary endothelial function; untreated aortic rings
Route (data field only)in-culture
Endpoints measuredaortic plasma MOTS-c (ELISA); coronary blood flow response to acetylcholine; microvascular and epicardial endothelial function; aortic ring responsiveness to acetylcholine
Pathways measuredNot reported
Research areasCardiovascular
Evidence tierB — Other human study
Publication typesJournal Article, Research Support, Non-U.S. Gov't

Appraisal

Each dimension is recorded separately and never combined into a single score. A study can be well controlled and still tell you little about people.

Relevance to MOTS-c
Direct
Model applicability
Human
Sample size
Small
Controls
Appropriate
Outcome validity
Validated biomarker
Support for its own conclusion
Moderate

Provenance

  • Bibliographic fields retrieved from PubMed E-utilities efetch (title, journal, date, authors, DOI) on 2026-11-11.
  • Annotated from the published abstract.
  • Editorial review: approved (2026-11-11).
  • Classification follows the site methodology; the record describes the study, not what MOTS-c does in people.